Sei Investments Co. Grows Stake in Azenta, Inc. (NASDAQ:AZTA)

Sei Investments Co. lifted its stake in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 59.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 152,536 shares of the company's stock after buying an additional 56,590 shares during the period. Sei Investments Co. owned approximately 0.33% of Azenta worth $7,627,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Cerity Partners LLC lifted its position in Azenta by 21.2% in the third quarter. Cerity Partners LLC now owns 39,031 shares of the company's stock valued at $1,891,000 after purchasing an additional 6,840 shares during the last quarter. BNP Paribas Financial Markets increased its stake in shares of Azenta by 285.8% in the third quarter. BNP Paribas Financial Markets now owns 31,227 shares of the company's stock worth $1,513,000 after buying an additional 23,132 shares during the period. Glenmede Trust Co. NA raised its holdings in Azenta by 6.3% during the 3rd quarter. Glenmede Trust Co. NA now owns 11,379 shares of the company's stock valued at $551,000 after buying an additional 679 shares during the last quarter. Verition Fund Management LLC purchased a new stake in Azenta during the 3rd quarter valued at $873,000. Finally, American Capital Management Inc. grew its holdings in Azenta by 4.0% in the 3rd quarter. American Capital Management Inc. now owns 340,501 shares of the company's stock worth $16,494,000 after acquiring an additional 13,033 shares during the last quarter. Institutional investors own 99.08% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Needham & Company LLC increased their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a report on Thursday, February 6th. TD Cowen raised Azenta to a "hold" rating in a research note on Thursday, February 27th. Evercore ISI upped their target price on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Finally, Stephens reiterated an "overweight" rating and issued a $60.00 price target on shares of Azenta in a report on Thursday, January 2nd. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Azenta has a consensus rating of "Hold" and a consensus price target of $58.75.

Remove Ads

Azenta Stock Performance

Shares of AZTA traded down $4.11 on Thursday, reaching $31.30. The stock had a trading volume of 686,866 shares, compared to its average volume of 610,934. Azenta, Inc. has a 12-month low of $31.09 and a 12-month high of $63.58. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of -10.50 and a beta of 1.52. The company has a 50-day simple moving average of $43.51 and a 200-day simple moving average of $45.90.

Azenta (NASDAQ:AZTA - Get Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. On average, analysts expect that Azenta, Inc. will post 0.53 EPS for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.